Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Short summary

Solid tumors with mismatch repair deficiency show a high response rate to PD-1 blockade therapy, with 53% objective radiographic responses and 21% complete responses across 12 tumor types.

AI-generated from the title and abstract; the full text is not read.